PHARMADANICA A/S: Financial statements 2013
CVR: 19056007
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
PHARMADANICA A/S (CVR 19056007) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -2,570 and a net result of DKK -85,665. Equity in the 2013 report amounted to DKK -771,032.
- Gross Profit
- DKK -2,570
- Profit/Loss
- DKK -85,665
- Equity
- DKK -771,032
- Total Assets
- DKK 57,395
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
PHARMADANICA A/S has published its interim report for the period May 1, 2012 to December 31, 2012.
As of March 15, 2013, Kim Erik Ginnerup is registered as adm. dir. of PHARMADANICA A/S.
As of March 15, 2013, Mikkel Mørkedal Wakefield has stepped down as adm. dir. of PHARMADANICA A/S.
About PHARMADANICA A/S
PHARMADANICA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named A/S PSE NR. 4943. The management consists of Jean-Marc Pierre Rene Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre Rene Leccia. The company is owned by MISSIONPHARMA A/S. The company has 3 employees (2004). In 2026, the company reported a net result of DKK 4,314,032 compared with DKK -339,647 the year before. Equity in the 2026 report amounted to DKK 20,960,385.